SCPEP1
gene geneOn this page
Also known as RISC
Summary
SCPEP1 (serine carboxypeptidase 1, HGNC:29507) is a protein-coding gene on chromosome 17q22, encoding Retinoid-inducible serine carboxypeptidase (Q9HB40). May be involved in vascular wall and kidney homeostasis.
Predicted to enable serine-type carboxypeptidase activity. Predicted to be involved in negative regulation of blood pressure and retinoic acid metabolic process. Predicted to act upstream of or within blood vessel diameter maintenance. Located in extracellular exosome.
Source: NCBI Gene 59342 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 91 total
- Druggable target: yes
- MANE Select transcript:
NM_021626
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:29507 |
| Approved symbol | SCPEP1 |
| Name | serine carboxypeptidase 1 |
| Location | 17q22 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | RISC |
| Ensembl gene | ENSG00000121064 |
| Ensembl biotype | protein_coding |
| OMIM | 619723 |
| Entrez | 59342 |
Gene structure
Transcript identifiers
Ensembl transcripts: 22 — 11 protein_coding, 5 retained_intron, 3 protein_coding_CDS_not_defined, 3 nonsense_mediated_decay
ENST00000262288, ENST00000570479, ENST00000570480, ENST00000570505, ENST00000570589, ENST00000571345, ENST00000571898, ENST00000572591, ENST00000572710, ENST00000573239, ENST00000573789, ENST00000573823, ENST00000575395, ENST00000575423, ENST00000576154, ENST00000631024, ENST00000858469, ENST00000858470, ENST00000858471, ENST00000914327, ENST00000914328, ENST00000951949
RefSeq mRNA: 1 — MANE Select: NM_021626
NM_021626
CCDS: CCDS11593
Canonical transcript exons
ENST00000262288 — 13 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002642237 | 57006173 | 57006768 |
| ENSE00003473838 | 57000855 | 57000992 |
| ENSE00003499376 | 56995507 | 56995635 |
| ENSE00003511507 | 56981082 | 56981230 |
| ENSE00003513297 | 57002018 | 57002181 |
| ENSE00003568138 | 56996962 | 56997055 |
| ENSE00003570536 | 56994981 | 56995018 |
| ENSE00003586820 | 56998385 | 56998498 |
| ENSE00003589911 | 56988216 | 56988290 |
| ENSE00003593580 | 56987695 | 56987850 |
| ENSE00003597306 | 56985378 | 56985467 |
| ENSE00003621458 | 56978131 | 56978235 |
| ENSE00003790843 | 56991099 | 56991171 |
Expression profiles
Bgee: expression breadth ubiquitous, 290 present calls, max score 99.26.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 56.4624 / max 560.9933, expressed in 1819 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 161823 | 56.4624 | 1819 |
Top tissues by expression
294 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right adrenal gland cortex | UBERON:0035827 | 99.26 | gold quality |
| monocyte | CL:0000576 | 99.15 | gold quality |
| right adrenal gland | UBERON:0001233 | 99.13 | gold quality |
| adrenal tissue | UBERON:0018303 | 98.96 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 98.96 | gold quality |
| left adrenal gland | UBERON:0001234 | 98.94 | gold quality |
| mononuclear cell | CL:0000842 | 98.92 | gold quality |
| adrenal cortex | UBERON:0001235 | 98.92 | gold quality |
| leukocyte | CL:0000738 | 98.81 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 98.69 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 98.68 | gold quality |
| adrenal gland | UBERON:0002369 | 98.66 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 98.48 | gold quality |
| thyroid gland | UBERON:0002046 | 98.46 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 98.37 | gold quality |
| gall bladder | UBERON:0002110 | 98.09 | gold quality |
| thoracic aorta | UBERON:0001515 | 98.07 | gold quality |
| ascending aorta | UBERON:0001496 | 98.03 | gold quality |
| mucosa of stomach | UBERON:0001199 | 97.96 | gold quality |
| right coronary artery | UBERON:0001625 | 97.96 | gold quality |
| minor salivary gland | UBERON:0001830 | 97.88 | gold quality |
| right lung | UBERON:0002167 | 97.81 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 97.80 | gold quality |
| lower esophagus | UBERON:0013473 | 97.68 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 97.68 | gold quality |
| saliva-secreting gland | UBERON:0001044 | 97.63 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 97.58 | gold quality |
| epithelium of bronchus | UBERON:0002031 | 97.57 | gold quality |
| skin of abdomen | UBERON:0001416 | 97.56 | gold quality |
| left coronary artery | UBERON:0001626 | 97.53 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 3.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-HCAD-1 | yes | 645.00 |
| E-MTAB-10553 | yes | 4.99 |
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
34 targeting SCPEP1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-5011-5P | 100.00 | 83.46 | 5820 |
| HSA-MIR-190A-3P | 100.00 | 80.35 | 5520 |
| HSA-MIR-1277-5P | 100.00 | 73.95 | 5056 |
| HSA-MIR-3924 | 100.00 | 72.09 | 2394 |
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-196A-1-3P | 99.99 | 72.15 | 2772 |
| HSA-MIR-3658 | 99.96 | 73.87 | 4379 |
| HSA-MIR-1250-3P | 99.96 | 70.04 | 4038 |
| HSA-MIR-7-1-3P | 99.91 | 71.53 | 4384 |
| HSA-MIR-7-2-3P | 99.91 | 71.40 | 4394 |
| HSA-MIR-153-5P | 99.89 | 73.86 | 6317 |
| HSA-MIR-579-3P | 99.86 | 71.66 | 3628 |
| HSA-MIR-664B-3P | 99.84 | 71.65 | 3590 |
| HSA-MIR-489-3P | 99.80 | 66.46 | 839 |
| HSA-MIR-4729 | 99.69 | 72.18 | 4233 |
| HSA-MIR-3942-3P | 99.57 | 69.03 | 2854 |
| HSA-MIR-103A-1-5P | 99.39 | 67.78 | 1545 |
| HSA-MIR-103A-2-5P | 99.39 | 67.72 | 1577 |
| HSA-MIR-5683 | 99.36 | 68.59 | 2083 |
| HSA-MIR-580-5P | 99.28 | 70.94 | 1776 |
| HSA-MIR-329-5P | 99.27 | 68.11 | 1597 |
| HSA-MIR-664A-3P | 99.22 | 71.08 | 2696 |
| HSA-MIR-1253 | 99.12 | 67.08 | 1688 |
| HSA-MIR-3146 | 98.85 | 66.77 | 601 |
| HSA-MIR-2276-3P | 98.76 | 67.75 | 1384 |
| HSA-MIR-9903 | 98.47 | 66.70 | 748 |
| HSA-MIR-3977 | 98.00 | 68.17 | 1500 |
| HSA-MIR-6787-3P | 97.75 | 66.17 | 1233 |
| HSA-MIR-6836-3P | 97.08 | 64.99 | 712 |
Literature-anchored findings (GeneRIF, showing 2)
- RACK1 binds to KH-type splicing regulatory protein (KSRP), a member of the Dicer complex, and is required for the recruitment of mature miRNAs to the RNA-induced silencing complex (RISC). (PMID:21935400)
- The structures of active lysosomal serine carboxypeptidase cathepsin A and the inactive precursor are very similar. (PMID:24530914)
Cross-species orthologs
9 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | scpep1 | ENSDARG00000040072 |
| mus_musculus | Scpep1 | ENSMUSG00000000278 |
| rattus_norvegicus | Scpep1 | ENSRNOG00000002358 |
| drosophila_melanogaster | hiro | FBGN0035154 |
| drosophila_melanogaster | CG31821 | FBGN0051821 |
| drosophila_melanogaster | CG31823 | FBGN0051823 |
| drosophila_melanogaster | CG32483 | FBGN0052483 |
| caenorhabditis_elegans | WBGENE00009058 | |
| caenorhabditis_elegans | WBGENE00012530 |
Paralogs (2): CTSA (ENSG00000064601), CPVL (ENSG00000106066)
Protein
Protein identifiers
Retinoid-inducible serine carboxypeptidase — Q9HB40 (reviewed: Q9HB40)
Alternative names: Serine carboxypeptidase 1
All UniProt accessions (6): Q9HB40, I3L195, I3L2N6, I3L4Z3, I3L4Z9, I3L506
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in vascular wall and kidney homeostasis.
Subcellular location. Secreted.
Miscellaneous. May be produced at very low levels due to a premature stop codon in the mRNA, leading to nonsense-mediated mRNA decay.
Similarity. Belongs to the peptidase S10 family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9HB40-1 | 1 | yes |
| Q9HB40-2 | 2 |
RefSeq proteins (1): NP_067639* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001563 | Peptidase_S10 | Family |
| IPR018202 | Ser_caboxypep_ser_AS | Active_site |
| IPR029058 | AB_hydrolase_fold | Homologous_superfamily |
Pfam: PF00450
UniProt features (12 total): active site 3, glycosylation site 3, sequence variant 2, splice variant 2, signal peptide 1, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9HB40-F1 | 90.20 | 0.83 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Catalytic / active sites (3): 167; 371; 431
Glycosylation sites (3): 64, 126, 362
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 205 (showing top):
GOBP_REGULATION_OF_BLOOD_PRESSURE, GOBP_CIRCULATORY_SYSTEM_PROCESS, GOZGIT_ESR1_TARGETS_DN, MODULE_511, GOBP_REGULATION_OF_HORMONE_LEVELS, SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN, GOBP_MONOCARBOXYLIC_ACID_METABOLIC_PROCESS, GOLDRATH_ANTIGEN_RESPONSE, GOBP_REGULATION_OF_ANATOMICAL_STRUCTURE_SIZE, ROSS_LEUKEMIA_WITH_MLL_FUSIONS, GOBP_RETINOIC_ACID_METABOLIC_PROCESS, GOBP_LIPID_METABOLIC_PROCESS, GOBP_ORGANIC_ACID_METABOLIC_PROCESS, GOBP_NEGATIVE_REGULATION_OF_BLOOD_PRESSURE, CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN
GO Biological Process (5): proteolysis (GO:0006508), retinoic acid metabolic process (GO:0042573), negative regulation of blood pressure (GO:0045776), blood vessel diameter maintenance (GO:0097746), regulation of biological quality (GO:0065008)
GO Molecular Function (4): serine-type carboxypeptidase activity (GO:0004185), carboxypeptidase activity (GO:0004180), peptidase activity (GO:0008233), hydrolase activity (GO:0016787)
GO Cellular Component (2): extracellular exosome (GO:0070062), extracellular region (GO:0005576)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| protein metabolic process | 1 |
| retinoid metabolic process | 1 |
| monocarboxylic acid metabolic process | 1 |
| hormone metabolic process | 1 |
| regulation of blood pressure | 1 |
| vascular process in circulatory system | 1 |
| blood circulation | 1 |
| regulation of tube diameter | 1 |
| biological regulation | 1 |
| carboxypeptidase activity | 1 |
| serine-type exopeptidase activity | 1 |
| exopeptidase activity | 1 |
| hydrolase activity | 1 |
| catalytic activity, acting on a protein | 1 |
| catalytic activity | 1 |
| extracellular vesicle | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
1533 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SCPEP1 | PTTG1IP | P53801 | 498 |
| SCPEP1 | RASL10B | Q96S79 | 476 |
| SCPEP1 | AHDC1 | Q5TGY3 | 420 |
| SCPEP1 | ABHD10 | Q9NUJ1 | 416 |
| SCPEP1 | C17orf67 | Q0P5P2 | 414 |
| SCPEP1 | SMTNL2 | Q2TAL5 | 414 |
| SCPEP1 | ANKFN1 | Q8N957 | 411 |
| SCPEP1 | UTS2R | Q9UKP6 | 408 |
| SCPEP1 | JAKMIP2 | Q96AA8 | 399 |
| SCPEP1 | ABHD14B | Q96IU4 | 376 |
| SCPEP1 | GRIP2 | Q9C0E4 | 376 |
| SCPEP1 | FAM151B | Q6UXP7 | 361 |
| SCPEP1 | AKAP1 | Q92667 | 358 |
| SCPEP1 | LYPLA2 | O95372 | 355 |
| SCPEP1 | APP | P05067 | 349 |
IntAct
27 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ADAMTS4 | MANBA | psi-mi:“MI:0914”(association) | 0.530 |
| LPAR1 | TMEM223 | psi-mi:“MI:0914”(association) | 0.530 |
| ZSCAN21 | LRP4 | psi-mi:“MI:0914”(association) | 0.530 |
| HSCB | RBP5 | psi-mi:“MI:0914”(association) | 0.350 |
| TANK | CNOT1 | psi-mi:“MI:0914”(association) | 0.350 |
| TEX101 | PSMD12 | psi-mi:“MI:0914”(association) | 0.350 |
| TEX101 | NDUFA4 | psi-mi:“MI:0914”(association) | 0.350 |
| CANX | HLA-A | psi-mi:“MI:0914”(association) | 0.350 |
| SCPEP1 | CCDC85C | psi-mi:“MI:0914”(association) | 0.350 |
| BRICD5 | TMEM131L | psi-mi:“MI:0914”(association) | 0.350 |
| NCR3 | POTEF | psi-mi:“MI:0914”(association) | 0.350 |
| SH2D3A | A2ML1 | psi-mi:“MI:0914”(association) | 0.350 |
| PCP4 | A2ML1 | psi-mi:“MI:0914”(association) | 0.350 |
| NT5C1A | A2ML1 | psi-mi:“MI:0914”(association) | 0.350 |
| KLK15 | APAF1 | psi-mi:“MI:0914”(association) | 0.350 |
| EMP3 | NDUFS4 | psi-mi:“MI:0914”(association) | 0.350 |
| ATP6AP2 | KLK10 | psi-mi:“MI:0914”(association) | 0.350 |
| ZNF460 | TOMM40 | psi-mi:“MI:0914”(association) | 0.350 |
| IGF2R | MANBA | psi-mi:“MI:0914”(association) | 0.350 |
| BRICD5 | PODXL | psi-mi:“MI:0914”(association) | 0.350 |
| C1orf54 | QSOX1 | psi-mi:“MI:0914”(association) | 0.350 |
| C1QTNF9B | DNASE2 | psi-mi:“MI:0914”(association) | 0.350 |
| HPN | DDX39A | psi-mi:“MI:0914”(association) | 0.350 |
| LCN6 | HIGD1C | psi-mi:“MI:0914”(association) | 0.350 |
| SCPEP1 | CLGN | psi-mi:“MI:0914”(association) | 0.350 |
| TMEM25 | ATE1 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (88): CD2AP (Co-fractionation), PRDX6 (Co-fractionation), SCPEP1 (Co-fractionation), SCPEP1 (Co-fractionation), SCPEP1 (Co-fractionation), ZNF507 (Affinity Capture-MS), SCPEP1 (Affinity Capture-MS), SCPEP1 (Affinity Capture-MS), SCPEP1 (Affinity Capture-MS), SCPEP1 (Two-hybrid), SCPEP1 (Proximity Label-MS), SCPEP1 (Affinity Capture-MS), NCR3LG1 (Affinity Capture-MS), GMCL1 (Affinity Capture-MS), NAT14 (Affinity Capture-MS)
ESM2 similar proteins: A5D6U8, A6H730, J3SDX8, O16956, O35409, O61866, O75795, P04068, P04634, P07098, P07099, P07687, P08430, P0DTE5, P11515, P19224, P21529, P36510, P37891, P38571, P49614, P70627, P70691, P79381, P80035, Q28611, Q29458, Q38924, Q3U4B4, Q3YBN2, Q41005, Q4R4S5, Q5VXI9, Q5VXJ0, Q5VYY2, Q5W064, Q64194, Q64435, Q64550, Q67ZU1
Diamond homologs: A5YCB8, A7UKV5, B2AWD5, B6HPP6, B6V867, B8NXS9, C4JNM2, C5FGX1, C5FW30, D4AIF1, D4AP52, D4AQ54, D4AZ71, D4AZG9, D4B0Q6, D4DD24, D4DLI1, O04084, O64811, P32825, P34946, P52708, P52714, P52716, P52719, Q2H9G6, Q2TYA1, Q2V465, Q4QR71, Q5J6J1, Q5J6J2, Q67Y83, Q8H780, Q8RUW5, Q8RWJ6, Q9CAU0, Q9CAU1, Q9CAU2, Q9CAU3, Q9CAU4
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
91 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 67 |
| Likely benign | 3 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1920 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 17:56978232:GCAG:G | donor_gain | 1.0000 |
| 17:56978234:AGG:A | donor_loss | 1.0000 |
| 17:56978235:GGTA:G | donor_loss | 1.0000 |
| 17:56978236:GT:G | donor_loss | 1.0000 |
| 17:56978237:T:A | donor_loss | 1.0000 |
| 17:56981226:TTCAG:T | donor_loss | 1.0000 |
| 17:56981227:TCAG:T | donor_loss | 1.0000 |
| 17:56981228:CAG:C | donor_loss | 1.0000 |
| 17:56981229:AGG:A | donor_loss | 1.0000 |
| 17:56981230:GGT:G | donor_loss | 1.0000 |
| 17:56981231:GT:G | donor_loss | 1.0000 |
| 17:56981232:T:A | donor_loss | 1.0000 |
| 17:56985473:G:GG | donor_gain | 1.0000 |
| 17:56985490:C:G | donor_gain | 1.0000 |
| 17:56987685:T:TA | acceptor_gain | 1.0000 |
| 17:56987847:CCAGG:C | donor_loss | 1.0000 |
| 17:56987849:AGGT:A | donor_loss | 1.0000 |
| 17:56987851:G:T | donor_loss | 1.0000 |
| 17:56987852:T:A | donor_loss | 1.0000 |
| 17:56988214:A:AG | acceptor_gain | 1.0000 |
| 17:56988215:G:GG | acceptor_gain | 1.0000 |
| 17:56988215:GAC:G | acceptor_gain | 1.0000 |
| 17:56988215:GACA:G | acceptor_gain | 1.0000 |
| 17:56988286:ATAAG:A | donor_loss | 1.0000 |
| 17:56988287:TAAGG:T | donor_loss | 1.0000 |
| 17:56988288:AAGG:A | donor_loss | 1.0000 |
| 17:56988289:AGGTA:A | donor_loss | 1.0000 |
| 17:56988290:G:GA | donor_loss | 1.0000 |
| 17:56988291:G:T | donor_loss | 1.0000 |
| 17:56988292:T:A | donor_loss | 1.0000 |
AlphaMissense
2968 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 17:56981222:T:A | W73R | 0.998 |
| 17:56981222:T:C | W73R | 0.998 |
| 17:56985413:C:A | N87K | 0.997 |
| 17:56985413:C:G | N87K | 0.997 |
| 17:56985465:T:A | W105R | 0.997 |
| 17:56985465:T:C | W105R | 0.997 |
| 17:56987746:A:C | S123R | 0.996 |
| 17:56987748:T:A | S123R | 0.996 |
| 17:56987748:T:G | S123R | 0.996 |
| 17:56988243:T:C | S167P | 0.996 |
| 17:56981159:T:C | F52L | 0.995 |
| 17:56981161:C:A | F52L | 0.995 |
| 17:56981161:C:G | F52L | 0.995 |
| 17:56985396:A:C | S82R | 0.995 |
| 17:56985398:C:A | S82R | 0.995 |
| 17:56985398:C:G | S82R | 0.995 |
| 17:56987722:G:C | D115H | 0.995 |
| 17:56985427:G:A | G92E | 0.994 |
| 17:56987740:G:T | G121W | 0.994 |
| 17:57000972:A:T | D371V | 0.994 |
| 17:56987741:G:A | G121E | 0.993 |
| 17:56988283:T:C | L180P | 0.993 |
| 17:57000971:G:C | D371H | 0.993 |
| 17:57000972:A:C | D371A | 0.993 |
| 17:57000973:T:A | D371E | 0.993 |
| 17:57000973:T:G | D371E | 0.993 |
| 17:57002029:T:A | W382R | 0.993 |
| 17:57002029:T:C | W382R | 0.993 |
| 17:56981224:G:C | W73C | 0.992 |
| 17:56981224:G:T | W73C | 0.992 |
dbSNP variants (sampled 300 via entrez): RS1000028895 (17:56996506 C>T), RS1000049789 (17:57006853 A>G), RS1000059903 (17:56996370 A>G), RS1000573656 (17:56981986 G>A), RS1000871268 (17:56984034 G>A), RS1001151254 (17:56977547 A>G), RS1001216679 (17:57000293 T>C), RS1001390362 (17:56990806 G>C), RS1001443701 (17:56998464 G>C), RS1001694132 (17:56982567 T>C), RS1001703788 (17:56997150 A>G), RS1001787297 (17:56982350 G>A), RS1001855809 (17:57000654 G>C), RS1001983101 (17:57001680 T>G), RS1002065338 (17:56978034 G>C)
Disease associations
OMIM: gene MIM:619723 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: yes
ChEMBL targets (1): CHEMBL2189131 (SINGLE PROTEIN)
PharmGKB: 1 entry (VIP=true, CPIC=false)
GtoPdb / IUPHAR curated pharmacology
(IUPHAR/BPS Guide to Pharmacology — expert-curated)
Target class: enzyme — S10: Carboxypeptidase Y
CTD chemical–gene interactions
45 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects cotreatment, increases expression, affects expression | 8 |
| bisphenol A | affects expression, increases expression | 2 |
| sodium arsenite | decreases expression | 2 |
| cobaltous chloride | increases expression | 2 |
| Vorinostat | decreases expression, increases expression | 2 |
| Cisplatin | increases expression, affects cotreatment | 2 |
| Tretinoin | increases expression | 2 |
| testosterone enanthate | affects expression | 1 |
| methylmercuric chloride | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| glycidyl methacrylate | decreases expression | 1 |
| trichostatin A | affects expression | 1 |
| beta-methylcholine | affects expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| entinostat | increases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, increases expression | 1 |
| dorsomorphin | affects cotreatment, increases expression | 1 |
| jinfukang | affects cotreatment, increases expression | 1 |
| bisphenol AF | increases expression | 1 |
| 4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid | decreases expression | 1 |
| Bortezomib | increases expression | 1 |
| Resveratrol | affects cotreatment, increases expression | 1 |
| Arsenic Trioxide | increases expression | 1 |
| Acetaminophen | increases expression | 1 |
| Air Pollutants | affects expression, increases abundance | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Calcitriol | increases expression | 1 |
| Doxorubicin | increases expression | 1 |
| Ethyl Methanesulfonate | increases expression | 1 |
| Formaldehyde | increases expression | 1 |
ChEMBL screening assays
1 unique, capped per target: 1 binding
Representative assays (with source publication via chembl_document):
| Assay ID | Type | Description | Source paper |
|---|---|---|---|
| CHEMBL2209090 | Binding | Inhibition of SCPEP1 binding to FP-biotin in [12C][14N]-lysine, arginine and [13C6][15N2]-lysine, arginine labeled HEK293T cells at 20 uM after 1 hr by isotopic activity-based protein profiling-MudPIT assay | Discovery and optimization of sulfonyl acrylonitriles as selective, covalent inhibitors of protein phosphatase methylesterase-1. — J Med Chem |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.